Iovance Biotherapeutics Stock Technical Analysis
| IOVA Stock | USD 9.40 0.28 3.07% |
As of the 28th of November, Iovance Biotherapeutics retains the Risk Adjusted Performance of (0.03), market risk adjusted performance of (0.08), and Standard Deviation of 4.35. Iovance Biotherapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Iovance Biotherapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Iovance, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IovanceIovance |
Iovance Biotherapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 22.36 | Strong Buy | 15 | Odds |
Most Iovance analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Iovance stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Iovance Biotherapeutics, talking to its executives and customers, or listening to Iovance conference calls.
Iovance Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Iovance Biotherapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Iovance Biotherapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Iovance Biotherapeutics Trend Analysis
Use this graph to draw trend lines for Iovance Biotherapeutics. You can use it to identify possible trend reversals for Iovance Biotherapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Iovance Biotherapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Iovance Biotherapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Iovance Biotherapeutics applied against its price change over selected period. The best fit line has a slop of 0.006 , which may suggest that Iovance Biotherapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1.37, which is the sum of squared deviations for the predicted Iovance Biotherapeutics price change compared to its average price change.About Iovance Biotherapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Iovance Biotherapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Iovance Biotherapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Iovance Biotherapeutics price pattern first instead of the macroeconomic environment surrounding Iovance Biotherapeutics. By analyzing Iovance Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Iovance Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Iovance Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2023 | 2024 (projected) | Dividend Yield | 0.13 | 0.12 | 0.1 | Price To Sales Ratio | 1.6K | 1.4K | 1.3K |
Iovance Biotherapeutics November 28, 2024 Technical Indicators
Most technical analysis of Iovance help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Iovance from various momentum indicators to cycle indicators. When you analyze Iovance charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 3.31 | |||
| Coefficient Of Variation | (2,197) | |||
| Standard Deviation | 4.35 | |||
| Variance | 18.91 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 23.06 | |||
| Value At Risk | (6.95) | |||
| Potential Upside | 7.54 | |||
| Skewness | (0.15) | |||
| Kurtosis | 0.7554 |
Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance |